SANOFI patent applications published on September 12th, 2024

Summary of the patent applications from SANOFI on September 12th, 2024

• • Summary**:

Sanofi has recently filed patents for innovative technologies in the healthcare and pharmaceutical industries. These patents include a data collection apparatus for measuring medicament doses, a dose counting system for injection devices, a novel drug for treating inflammatory diseases, and an anticancer compound. The inventions focus on improving accuracy, safety, and efficacy in medication administration and treatment.

• • Key Points of Patents**:

- Data collection apparatus with gyroscope for dose measurement. - Dose counting system using sensors and processor for accurate dosing. - Novel drug with polypeptides for treating inflammatory diseases. - Anticancer compound with specific chemical structure for cancer treatment.

• • Notable Applications**:

- Enhanced accuracy in medication dosing and administration. - Improved treatment outcomes for inflammatory diseases and cancer. - Potential for targeted therapy with reduced side effects. - Market opportunities in pharmaceutical development and disease management.

Patent applications for SANOFI on September 12th, 2024

COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA (18594291)

Main Inventor

Nadège ARNAUD BARBE

Electric Coupling for Injection Devices (18663525)

Main Inventor

Bernd Kuehn

IMIDAZO[1,2-B][1,2,4]TRIAZOL DERIVATIVES FOR USE IN THERAPY ([[SANOFI (18578530). IMIDAZO[1,2-B][1,2,4]TRIAZOL DERIVATIVES FOR USE IN THERAPY simplified abstract|18578530]])

Main Inventor

Antonio ALMARIO

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING IL-6 AND TNF ALPHA (18398367)

Main Inventor

Heidi Rommelaere

A Dose Counting System (18275941)

Main Inventor

Alexander Allerdings

Data Collection Apparatus for Dose Determination (18574891)

Main Inventor

Michael Schabbach